rxstat › Drug prices › Garadacimab
Garadacimab (Andembry) price in Canada
No current shortage
Garadacimab 200 mg/1.2ml solution costs about $34840.00 per billed unit (often a pen or vial) on public drug plan price lists in Alberta, before the pharmacy's dispensing fee.
Garadacimab has no current shortage reported in Canada. No active reports are on file.
Price by province
| Strength and form | AB | SK | NS |
|---|---|---|---|
| 200 mg/1.2ml Solution | $34840.00/unit | $174.20/unit | $29033.33/unit |
| Plan coverage | Covered | Special approval | Special approval |
What you'll pay at the pharmacy
These are the prices public drug plans list for the drug itself. At the counter, pharmacies add a dispensing fee and in some provinces a markup, so paying cash costs more, and for cheap generics the fee is often more than the drug. If you have a public or private plan, your share depends on its deductible and co-pay.
Listed products by province
Alberta: 2 products
- Andembry 200 mg/1.2ml Solution · CSL
- Andembry 200 mg/1.2ml Solution · CSL
Saskatchewan: 1 product
- Andembry 200 mg/1.2ml Solution · CSL
Nova Scotia: 1 product
- Andembry 200 mg/1.2ml Solution · CSL
Shortage status
No shortage or discontinuation reports have been filed with Health Canada for Garadacimab. rxstat watches those reports through the day; sign up below to hear if that changes.
Common questions
How much does Garadacimab cost in Canada?
Garadacimab 200 mg/1.2ml solution costs about $34840.00 per billed unit (often a pen or vial) on public drug plan price lists in Alberta, before the pharmacy's dispensing fee.
Is Garadacimab covered by provincial drug plans?
On the public plans' own lists: Alberta: covered; Saskatchewan: special approval; Nova Scotia: special approval. "Special approval" means the plan covers it only for some patients, on a request from the prescriber. "Price list" means the province publishes its price but not its coverage.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Related drugs (other hematological agents)
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.